+232 76 258 258 info@vsltravel.com

Corgenix and Research Partners to Expand Ebola Virus Testing Capabilities in Sierra Leone

DENVER, Mar 27, 2014 (BUSINESS WIRE) — An outbreak of the deadly Ebola virus in West Africa has promptedCorgenix Medical CorporationCONX -12.64% to extend its existing viral hemorrhagic fever (VHF)

rapid test development to include the Ebola virus. Corgenix has already developed and CE marked a rapid test for the Lassa fever virus, another member of the VHF group of viruses.